Registration device for blood test strips
-
0Associated
Cases -
0Associated
Defendants -
0Accused
Products -
134Forward
Citations -
0
Petitions -
4
Assignments
First Claim
1. A system of testing for glucose in whole blood comprising:
- a cylindrical vial for containing a plurality of inactivated test strips which are selectively removable therefrom, each test strip provided with a reagent area adapted to receive a blood sample thereon and thereby being activated to indicate a particular color consistent with the condition of the blood and the time elapsed since reception of the blood sample thereon, said vial having an outer peripheral surface;
a plurality of graduated markings on said peripheral surface providing a range of different colors which are indicative of a range of possible conditions which might be evidenced by an activated test strip;
holder means slidably mounted on said outer peripheral surface and including a support region for slidably receiving the reagent area of an activated test strip, said holder means defining a window for outlining, simultaneously, at least one of said markings on said peripheral surface and on the reagent area of the activated test strip;
thereby enabling the reagent area on the activated test strip to be matched with an appropriate one of said markings on said peripheral surface to thereby indicate the condition of the blood being sampled.
4 Assignments
0 Petitions

Accused Products

Abstract
A ring-shaped registration device for receiving and holding an activated test strip having a reagent area adapted to receive a blood sample. The registration device is slidably received on the outer peripheral surface of a cylindrical vial on which markings to indicate a range of possible results which might be evidenced by a blood sample. The device includes a central member having a support region for slidably receiving the activated test strip and defining a window for outlining markings on the surface of the vial and on the reagent area of the activated test strip. The reagent area is held in substantially tangential relationship relative to the outer peripheral surface of the vial so as to be selectively positioned intermediate adjacent markings on the surface of the vial. This enables the user to compare an actual blood sample with the range of possible conditions and match the sample with the markings on the vial.
137 Citations
Reagent stripe for test strip | ||
Patent #
US 7,892,849 B2
Filed 02/20/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
TEST STRIP WITH SLOT VENT OPENING | ||
Patent #
US 20110011738A1
Filed 09/23/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
TEST STRIP WITH SLOT VENT OPENING | ||
Patent #
US 20110000610A1
Filed 09/15/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and reagent for producing narrow, homogenous reagent strips | ||
Patent #
US 7,879,618 B2
Filed 01/29/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Method of making a diagnostic test strip having a coding system | ||
Patent #
US 7,955,856 B2
Filed 11/09/2006
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Gross Hematuria Evaluator and Methods for Making and Using Same | ||
Patent #
US 20110111451A1
Filed 11/12/2009
|
Current Assignee
Steven Y. Chung
|
Sponsoring Entity
Steven Y. Chung
|
Test strip card | ||
Patent #
US 8,003,061 B2
Filed 05/06/2004
|
Current Assignee
Akers Biosciences Inc.
|
Sponsoring Entity
Akers Biosciences Inc.
|
System and method for determining an abused sensor during analyte measurement | ||
Patent #
US 7,977,112 B2
Filed 12/09/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Method for coding information on a biosensor test strip | ||
Patent #
US 8,058,077 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 7,645,421 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 7,645,373 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Reagent stripe for test strip | ||
Patent #
US 7,727,467 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
SYSTEM AND METHOD FOR CODING INFORMATION ON A BIOSENSOR TEST STRIP | ||
Patent #
US 20100111764A1
Filed 12/17/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 7,718,439 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
SYSTEM AND METHOD FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A SAMPLE FLUID | ||
Patent #
US 20100170807A1
Filed 12/30/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and reagent for producing narrow, homogenous reagent stripes | ||
Patent #
US 7,749,437 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Test strip with vent opening | ||
Patent #
US 7,829,023 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
BIOSENSOR AND METHOD OF MAKING | ||
Patent #
US 20090020502A1
Filed 09/25/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method for determining a test strip calibration code using a calibration strip | ||
Patent #
US 7,474,391 B2
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan Scotland Limited
|
Test strip with permutative grey scale calibration pattern | ||
Patent #
US 7,474,390 B2
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan Scotland Limited
|
SYSTEM AND METHOD FOR ANALYTE MEASUREMENT USING DOSE SUFFICIENCY ELECTRODES | ||
Patent #
US 20090045076A1
Filed 10/20/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
System and method for determining a temperature during analyte measurement | ||
Patent #
US 7,494,816 B2
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for determining an abused sensor during analyte measurement | ||
Patent #
US 7,488,601 B2
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
METHOD AND REAGENT FOR PRODUCING NARROW, HOMOGENOUS REAGENT STRIPS | ||
Patent #
US 20090162532A1
Filed 01/29/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Electrode design for biosensor | ||
Patent #
US 7,556,723 B2
Filed 01/12/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for quality assurance of a biosensor test strip | ||
Patent #
US 7,569,126 B2
Filed 10/08/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Calibration code strip with permutative grey scale calibration pattern | ||
Patent #
US 7,586,590 B2
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan Scotland Limited
|
Method for determining a test strip calibration code for use in a meter | ||
Patent #
US 7,593,097 B2
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan Scotland Limited
|
System for analyte determination that includes a permutative grey scale calibration pattern | ||
Patent #
US 7,589,828 B2
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan Scotland Limited
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 7,604,721 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for analyte measurement employing maximum dosing time delay | ||
Patent #
US 7,597,793 B2
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
DIAGNOSTIC STRIP CODING SYSTEM WITH CONDUCTIVE LAYERS | ||
Patent #
US 20080020452A1
Filed 07/18/2006
|
Current Assignee
Nipro Diagnostics Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Fluid tester and method of use | ||
Patent #
US 7,319,037 B1
Filed 05/14/2002
|
Current Assignee
Orit Albeck-Marom
|
Sponsoring Entity
Orit Albeck-Marom
|
Underwear-Integrated Urine Specimen Collection System and Method Thereof | ||
Patent #
US 20080051742A1
Filed 07/15/2005
|
Current Assignee
Sybil Ingram-Campbell
|
Sponsoring Entity
Sybil Ingram-Campbell
|
Meter for an integrated diagnostic test system | ||
Patent #
D561904S1
Filed 01/31/2005
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Home Diagnostics Incorporated
|
System and method for analyte measurement | ||
Patent #
US 7,338,639 B2
Filed 03/16/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for analyte measurement using AC phase angle measurements | ||
Patent #
US 7,390,667 B2
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for analyte measurement using AC excitation | ||
Patent #
US 7,407,811 B2
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
System and method for analyte measurement using dose sufficiency electrodes | ||
Patent #
US 7,452,457 B2
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Diagnostic strip coding system and related methods of use | ||
Patent #
US 20070015286A1
Filed 07/15/2005
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Trividia Health Inc.
|
Devices for analyte assays and methods of use | ||
Patent #
US 20070031914A1
Filed 08/05/2005
|
Current Assignee
Inverness Medical Switzerland GmbH
|
Sponsoring Entity
Inverness Medical Switzerland GmbH
|
Diagnostic strip coding system and related methods of use | ||
Patent #
US 20070110615A1
Filed 11/09/2006
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Trividia Health Inc.
|
Slide-in cassette for a cup for testing of drugs of abuse | ||
Patent #
US 7,244,392 B1
Filed 05/22/2000
|
Current Assignee
Inverness Medical Switzerland GmbH
|
Sponsoring Entity
Inverness Medical Switzerland GmbH
|
Calibration code strip with permutative grey scale calibration pattern | ||
Patent #
US 20070273901A1
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Method for determining a test strip calibration code for use in a meter | ||
Patent #
US 20070273904A1
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Test strip with permutative grey scale calibration pattern | ||
Patent #
US 20070273928A1
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Method for determining a test strip calibration code using a calibration strip | ||
Patent #
US 20070273903A1
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
System for analyte determination that includes a permutative grey scale calibration pattern | ||
Patent #
US 20070273902A1
Filed 05/26/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Biomedical electrochemical sensor array and method of fabrication | ||
Patent #
US 20060006141A1
Filed 11/15/2002
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Test strip container with integrated meter having strip coding capability | ||
Patent #
US 20060189895A1
Filed 02/13/2006
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Trividia Health Inc.
|
Reading devices and assay devices for use therewith | ||
Patent #
US 7,141,212 B2
Filed 11/09/1994
|
Current Assignee
Inverness Medical Switzerland GmbH
|
Sponsoring Entity
Inverness Medical Switzerland GmbH
|
Method of manufacturing a disposable diagnostic meter | ||
Patent #
US 20060275890A1
Filed 06/06/2005
|
Current Assignee
Home Diagnostics Incorporated
|
Sponsoring Entity
Home Diagnostics Incorporated
|
Method and reagent for producing narrow, homogenous reagent stripes | ||
Patent #
US 20050008537A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 20050019945A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Test strip with flared sample receiving chamber | ||
Patent #
US 20050019212A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Test strip with slot vent opening | ||
Patent #
US 20050013731A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 20050016846A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Reagent stripe for test strip | ||
Patent #
US 20050016844A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and apparatus for automatic analysis | ||
Patent #
US 6,852,212 B2
Filed 10/02/2001
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Biosensor and method of making | ||
Patent #
US 20050103624A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method for automatic analysis | ||
Patent #
US 20050126931A1
Filed 02/01/2005
|
Current Assignee
Alastair Mcindoe Hodges, Thomas William Beck, Ian Andrew Maxwell
|
Sponsoring Entity
Alastair Mcindoe Hodges, Thomas William Beck, Ian Andrew Maxwell
|
Meter for an integrated diagnostic test system | ||
Patent #
D506832S1
Filed 06/02/2004
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Home Diagnostics Incorporated
|
Meter for an integrated diagnostic test system | ||
Patent #
D507657S1
Filed 06/02/2004
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Home Diagnostics Incorporated
|
Biomedical electrochemical sensor array and method of fabrication | ||
Patent #
US 20050236361A1
Filed 03/14/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Test strip card | ||
Patent #
US 20050250218A1
Filed 05/06/2004
|
Current Assignee
Akers Biosciences Inc.
|
Sponsoring Entity
Akers Biosciences Inc.
|
Novel electrode design for biosensor | ||
Patent #
US 20050284758A1
Filed 01/12/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Antioxidant sensor | ||
Patent #
US 20040026244A1
Filed 07/31/2003
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Strip holder for use in a test strip meter | ||
Patent #
US 20040057878A1
Filed 09/24/2003
|
Current Assignee
House Allen, Lorin Olson
|
Sponsoring Entity
House Allen, Lorin Olson
|
System and method for analyte measurement using AC excitation | ||
Patent #
US 20040157339A1
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
-
|
System and method for analyte measurement using AC phase angle measurements | ||
Patent #
US 20040157337A1
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
-
|
Immunosensor | ||
Patent #
US 20040203137A1
Filed 04/22/2004
|
Current Assignee
Universal Biosensors Pty Ltd.
|
Sponsoring Entity
-
|
System and method for analyte measurement using dose sufficiency electrodes | ||
Patent #
US 20040256248A1
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
System and method for analyte measurement employing maximum dosing time delay | ||
Patent #
US 20040259180A1
Filed 10/17/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Device and method for collecting and testing fluid specimens | ||
Patent #
US 6,576,193 B1
Filed 10/27/2000
|
Current Assignee
Alice H. Yu, Shujie Cui
|
Sponsoring Entity
Alice H. Yu, Shujie Cui
|
Direct immunosensor assay | ||
Patent #
US 20030180814A1
Filed 03/21/2002
|
Current Assignee
Universal Biosensors Pty Ltd.
|
Sponsoring Entity
-
|
Hemoglobin sensor | ||
Patent #
US 20030201177A1
Filed 05/21/2003
|
Current Assignee
Alastair Hodges, Ron Chatelier, Thomas Beck
|
Sponsoring Entity
Ron Chatelier, Thomas Beck
|
Hemoglobin sensor | ||
Patent #
US 6,632,349 B1
Filed 07/14/2000
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Antioxidant sensor | ||
Patent #
US 6,638,415 B1
Filed 07/14/2000
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Strip holder for use in a test strip meter | ||
Patent #
US 6,652,814 B1
Filed 08/11/2000
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control | ||
Patent #
US 6,670,192 B1
Filed 01/05/2000
|
Current Assignee
John F. Burd, Gebhard Neyer, Talei Hoblitzell, Robert S. Galen
|
Sponsoring Entity
John F. Burd, Gebhard Neyer, Talei Hoblitzell, Robert S. Galen
|
Test element storage container | ||
Patent #
US 6,378,702 B1
Filed 11/28/2000
|
Current Assignee
Roche Diagnostics GmbH
|
Sponsoring Entity
Roche Diagnostics GmbH
|
Method and apparatus for automatic analysis | ||
Patent #
US 20020117404A1
Filed 10/02/2001
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Analytical system for sample liquids | ||
Patent #
US 6,176,119 B1
Filed 12/11/1998
|
Current Assignee
Roche Diagnostics GmbH
|
Sponsoring Entity
Roche Diagnostics GmbH
|
Method and apparatus for automatic analysis | ||
Patent #
US 6,325,917 B1
Filed 02/11/2000
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Large pore synthetic polymer membranes | ||
Patent #
US 5,979,670 A
Filed 06/11/1997
|
Current Assignee
USF Filtration and Separations Group Inc.
|
Sponsoring Entity
USF Filtration and Separations Group Inc.
|
Large pore synthetic polymer membranes | ||
Patent #
US 5,846,422 A
Filed 06/11/1996
|
Current Assignee
USF Filtration and Separations Group Inc.
|
Sponsoring Entity
USF Filtration and Separations Group Inc.
|
Method for determination of glycols and polyglycols in drilling fluid filtrates | ||
Patent #
US 5,627,076 A
Filed 11/13/1995
|
Current Assignee
Baker Hughes Incorporated
|
Sponsoring Entity
Baker Hughes Incorporated
|
Blood glucose reflectance meter including a null prompting means and a device for providing a constant brightness light | ||
Patent #
US 5,277,870 A
Filed 08/11/1992
|
Current Assignee
UMM ELECTRONICS INC.
|
Sponsoring Entity
UNITED MEDICAL MANUFACTURING COMPANY
|
Device for testing body fluids | ||
Patent #
US 5,178,831 A
Filed 08/15/1991
|
Current Assignee
Dai Nippon Insatsu Kab Ushiki Kaisha
|
Sponsoring Entity
Dai Nippon Insatsu Kab Ushiki Kaisha
|
Blood glucose reflectance meter including a null prompting means and a device for providing a constant brightness light | ||
Patent #
US 5,174,963 A
Filed 01/07/1991
|
Current Assignee
UMM ELECTRONICS INC.
|
Sponsoring Entity
UNITED MEDICAL MANUFACTURING COMPANY A DE CORP.
|
Color comparison device having a bulged insertion groove for holding a test stick in a flexed condition | ||
Patent #
US 4,984,895 A
Filed 03/13/1989
|
Current Assignee
Evenflo Company Incorporated
|
Sponsoring Entity
Omron Tateisi Electronics Co.
|
Device for testing fluids | ||
Patent #
US 5,004,584 A
Filed 06/23/1988
|
Current Assignee
Gerard A. Rayman
|
Sponsoring Entity
Gerard A. Rayman
|
Device for carrying out extemporaneous quantitative diagnostic tests on whole blood | ||
Patent #
US 5,071,772 A
Filed 02/07/1989
|
Current Assignee
Arturo Corchia, Raffaele Beli
|
Sponsoring Entity
Arturo Corchia, Raffaele Beli
|
Assay kit including an analyte test strip and a color comparator | ||
Patent #
US 4,877,580 A
Filed 02/09/1988
|
Current Assignee
Home Diagnostics Incorporated
|
Sponsoring Entity
TECHNIMED CORPORATION 4987 N.W. 23RD AVENUE FT. LAUDERDALE FLORIDA 33309
|
BIOSENSOR WITH LASER-SEALED CAPILLARY SPACE AND METHOD OF MAKING | ||
Patent #
US 20070278097A1
Filed 07/03/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Control and calibration solutions and methods for their use | ||
Patent #
US 8,071,384 B2
Filed 10/07/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 8,083,993 B2
Filed 12/17/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Test strip with flared sample receiving chamber | ||
Patent #
US 8,071,030 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for quality assurance of a biosensor test strip | ||
Patent #
US 8,092,668 B2
Filed 06/15/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Test strip with slot vent opening | ||
Patent #
US 8,119,414 B2
Filed 09/15/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for determining the concentration of an analyte in a sample fluid | ||
Patent #
US 8,148,164 B2
Filed 12/30/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Integrated diagnostic test system | ||
Patent #
US 8,147,426 B2
Filed 06/02/2004
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Test strip with slot vent opening | ||
Patent #
US 8,142,721 B2
Filed 09/23/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 8,206,565 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Test strip with slot vent opening | ||
Patent #
US 8,211,379 B2
Filed 09/20/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Test strip with flared sample receiving chamber | ||
Patent #
US 8,222,044 B2
Filed 11/16/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Biosensor and method of making | ||
Patent #
US 8,287,703 B2
Filed 09/25/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 8,293,538 B2
Filed 02/24/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
System and method for determining the concentration of an analyte in a sample fluid | ||
Patent #
US 8,298,828 B2
Filed 03/13/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Test strip container with integrated meter having strip coding capability | ||
Patent #
US 8,394,328 B2
Filed 02/13/2006
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Test strip container with integrated meter | ||
Patent #
US 8,394,337 B2
Filed 10/21/2005
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Gated voltammetry | ||
Patent #
US 8,404,100 B2
Filed 02/26/2008
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Bayer Healthcare LLC
|
Gated amperometry | ||
Patent #
US 8,425,757 B2
Filed 12/19/2007
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Bayer Healthcare LLC
|
Test strip card | ||
Patent #
US 8,425,859 B2
Filed 06/28/2011
|
Current Assignee
Akers Biosciences Inc.
|
Sponsoring Entity
Akers Biosciences Inc.
|
System and method for coding information on a biosensor test strip | ||
Patent #
US 8,507,289 B1
Filed 07/16/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Biosensor and method of making | ||
Patent #
US 8,551,308 B2
Filed 09/25/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
System and method for determining the concentration of an analyte in a sample fluid | ||
Patent #
US 8,586,373 B2
Filed 10/24/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Gated voltammetry devices | ||
Patent #
US 8,647,489 B2
Filed 02/28/2013
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Bayer Healthcare LLC
|
System and method for analyte measurement using dose sufficiency electrodes | ||
Patent #
US 8,663,442 B2
Filed 10/20/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Operations Limited
|
Biosensor with laser-sealed capillary space and method of making | ||
Patent #
US 8,679,853 B2
Filed 07/03/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Immunosensor | ||
Patent #
US 8,685,714 B2
Filed 04/22/2004
|
Current Assignee
Universal Biosensors Pty Ltd.
|
Sponsoring Entity
Universal Biosensors Pty Ltd.
|
Test strip card | ||
Patent #
US 8,808,639 B2
Filed 03/20/2013
|
Current Assignee
Akers Biosciences Inc.
|
Sponsoring Entity
Akers Biosciences Inc.
|
Method for determining whether a disposable, dry regent, electrochemical test strip is unsuitable for use | ||
Patent #
US 8,859,293 B2
Filed 06/02/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Gated amperometry methods | ||
Patent #
US 8,877,035 B2
Filed 03/28/2013
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Bayer Healthcare LLC
|
Embedded strip lot autocalibration | ||
Patent #
US 8,999,125 B2
Filed 05/06/2008
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Diagnostic strip coding system and related methods of use | ||
Patent #
US 9,012,232 B2
Filed 07/15/2005
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Nipro Diagnostics Inc.
|
Gated voltammetry methods | ||
Patent #
US 9,110,013 B2
Filed 12/20/2013
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Ascensia Diabetes Care Holdings AG
|
Method of using a biosensor | ||
Patent #
US 9,410,917 B2
Filed 02/28/2014
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Ascensia Diabetes Care Holdings AG
|
System and method for quality assurance of a biosensor test strip | ||
Patent #
US 9,410,915 B2
Filed 07/14/2014
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Devices using gated voltammetry methods | ||
Patent #
US 9,835,582 B2
Filed 07/10/2015
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Ascensia Diabetes Care Holdings AG
|
Biosensor apparatus and methods of use | ||
Patent #
US 9,863,942 B2
Filed 09/18/2009
|
Current Assignee
Universal Biosensors Pty Ltd.
|
Sponsoring Entity
Universal Biosensors Pty Ltd.
|
Embedded strip lot autocalibration | ||
Patent #
US 9,927,387 B2
Filed 03/03/2015
|
Current Assignee
Trividia Health Inc.
|
Sponsoring Entity
Trividia Health Inc.
|
Method of using an electrochemical test sensor | ||
Patent #
US 9,933,385 B2
Filed 09/19/2014
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Ascensia Diabetes Care Holdings AG
|
Biosensor for determining an analyte concentration | ||
Patent #
US 10,067,082 B2
Filed 06/29/2016
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
Ascensia Diabetes Care Holdings AG
|
Reagent test device holder | ||
Patent #
US 4,518,565 A
Filed 06/06/1983
|
Current Assignee
Miles Laboratories Inc.
|
Sponsoring Entity
Miles Laboratories Inc.
|
Detection of bacteria | ||
Patent #
US 4,336,337 A
Filed 06/16/1980
|
Current Assignee
Baylor College of Medicine
|
Sponsoring Entity
Baylor College of Medicine
|
Read-off device for medical samples | ||
Patent #
US 4,128,400 A
Filed 12/15/1976
|
Current Assignee
Compur-Electronic Gesellschaft mit beschrankter Haftung
|
Sponsoring Entity
Compur-Electronic Gesellschaft mit beschrankter Haftung
|
19 Claims
- 1. A system of testing for glucose in whole blood comprising:
a cylindrical vial for containing a plurality of inactivated test strips which are selectively removable therefrom, each test strip provided with a reagent area adapted to receive a blood sample thereon and thereby being activated to indicate a particular color consistent with the condition of the blood and the time elapsed since reception of the blood sample thereon, said vial having an outer peripheral surface; a plurality of graduated markings on said peripheral surface providing a range of different colors which are indicative of a range of possible conditions which might be evidenced by an activated test strip; holder means slidably mounted on said outer peripheral surface and including a support region for slidably receiving the reagent area of an activated test strip, said holder means defining a window for outlining, simultaneously, at least one of said markings on said peripheral surface and on the reagent area of the activated test strip; thereby enabling the reagent area on the activated test strip to be matched with an appropriate one of said markings on said peripheral surface to thereby indicate the condition of the blood being sampled. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
- 10. Apparatus enabling the reagent area of an activated test strip to which a blood sample has been applied to be matched with graduated markings indicative of a range of possible conditions which might be evidenced by a blood sample, which markings are provided on the outer peripheral surface of a cylindrical vial, comprising:
holder means slidably mounted on the outer peripheral surface of the vial and including a central member having a support region for slidably receiving and holding the activated test strip substantially tangent to the outer peripheral surface of the vial, said central member defining a window for outlining, simultaneously, at least one of the markings on the peripheral surface and on the reagent area of the activated test strip. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18, 19)
1 Specification
I. Field of the Invention
The present invention relates generally to a system of testing for glucose in whole blood and, more particularly, to a registration device for improving the ability of a user to obtain an accurate indication of the glucose level in his blood.
II. Description of the Prior Art
The present invention is intended for use with known self-administered tests used for determining the level of glucose in whole blood. Such a test has been developed and is marketed by Boehringer Mannheim Corporation of Indianapolis, Indiana under the registered trademark "CHEMSTRIP bG". In a customary manner, a cylindrical capped container or vial is provided with markings graduated by color as on a paper label adhesively applied to its outer peripheral surface. The markings are indicative of a range of possible conditions which might be evidenced by a blood sample. The vial contains a quantity of elongated flexible strips, each of which is intended for an individual test. Each strip is provided with a reagent area adjacent one end thereof. The normally inactive reagent area is activated when the user places a large drop of whole blood thereon. According to the usual test, the user simultaneously starts a timer. After a specified time interval, for example, 60 seconds, the blood is wiped off the reagent area as by the use of a dry cotton ball. After an additional specified time interval, for example, again 60 seconds, the color or colors appearing in the reagent area are matched by the user with the graduated markings on the outer surface of the vial. At this point, if a match is substantially obtained, the glucose level can be determined. However, if the color developed is darker than that of the darkest color appearing on the vial for the two minutes (120 second) range, then it is necessary to wait an additional 60 seconds before comparing the final reaction color with the color scale relating to a three minute duration.
Time is an important factor in performing the test. That is, the reagent area of the test strip continues to darken with the passage of time. Therefore, the test is only accurate if a color match is obtained at a finite point in time, that is, precisely after two minutes for the two minute scale or, precisely after three minutes for the three minute scale.
However, it will be appreciated that the users of self-administered tests such as the CHEMSTRIP bG test are diabetics who, in some instances, are unsteady with their hands. As a result, it may be difficult for such a user to obtain a color match within the necessarily tightly controlled duration of time.
It was with the knowledge of this drawback of the prior art that the present invention has been conceived and now reduced to practice.
The present invention is directed toward a ring-like registration device for receiving and holding an activated test strip having a reagent area adapted to receive a blood sample. The device is slidably received on the outer peripheral surface of a cylindrical vial on which are provided markings indicative of a range of possible results which might be evidenced by the blood sample. The device includes a central member having a support region for slidably receiving the activated test strip and defining a window for outlining markings on the surface of the vial and on the reagent area of the activated test strip. The reagent area is held in substantially tangential relationship relative to the outer peripheral surface of the vial so as to be selectively positioned intermediate adjacent markings on the surface of the vial. This enables the user to compare an actual blood sample with the range of possible conditions and match the sample with the markings on the vial.
The invention exhibits a number of features and benefits. In a first instance of such, it is of a simple construction which can be easily and inexpensively manufactured. Indeed, it might be desirable to provide the device of the invention with each vial and to discard it with the vial when the contained supply of test strips is exhausted.
As a further benefit, the invention can be readily used with the existing CHEMSTRIP bG glucose test system without requiring modification of that system in any manner.
Additionally, the operation of the invention can be readily learned and can be easily used by persons experiencing unsteadiness of hand. Furthermore, it assures accurate analysis even when performed by such an unsteady user.
Another feature of the invention resides its ability to be easily disassembled for cleaning, then re-assembled for use once again.
Other and further features, objects, advantages, and benefits of the invention will become apparent from the following description taken in conjunction with the following drawings. It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory but are not to be restrictive of the invention. The accompanying drawings which are incorporated in and constitute a part of this invention, illustrate one of the embodiments of the invention and, together with the description, serve to explain the principles of the invention in general terms. Like numerals refer to like parts through the disclosure.
FIG. 1 is a side elevation view generally illustrating one step of a known procedure for determining the level of glucose in a blood sample;
FIG. 2 is a perspective view of a registration device embodying the invention and illustrating its use in actual practice;
FIG. 3 is a top plan view of the structure illustrated in FIG. 2;
FIGS. 4 and 5 are cross section views taken, respectively, along lines 4--4 and 5--5 in FIG. 3;
FIG. 6 is a perspective exploded view of the invention and of a test strip utilized therewith;
FIGS. 7, 8, and 9 are top plan, front, and side elevation views, respectively, of a main component of the invention;
FIG. 10 is a cross section view taken generally along line 10--10 in FIG. 9; and
FIGS. 11, 12, 13, and 14, are, respectively, side elevation, top plan, front elevation, and bottom plan views of a subcomponent of the invention.
Turn now to the drawings and initially to FIG. 1 which illustrates a cylindrical capped container or vial 20 which may utilized for purposes of a self-administered test for determining the level of glucose in whole blood. The test may be, for example, one marketed by Boehringer Mannheim Corporation under the registered trademark CHEMSTRIP bG.
According to a known procedure, an elongated test strip 22 of flexible material is removed from the vial 20 which may contain a large quantity of similar test strips. The test strip has a reagent area 24 adapted to receive a large drop of whole blood in a known manner. The vial 20 is provided with a plurality of markings thereon graduated by color as on a paper label which may be adhesively applied to an outer peripheral surface 30 of the vial. A first aligned series 26 of graduated markings reflect a range of possible results of a two minute test while a second aligned series 28 of graduated markings reflect a range of possible results of a three minute test. The meaning of a two minute test and of a three minute test will now be explained.
At the moment that the user places a large drop of blood on the reagent area 24 of the test strip 22, he simultaneously starts a timer in operation. According to the test, after exactly 60 seconds have passed, he is required to wipe off the blood with a dry cotton ball or in some other suitable fashion. After an additional 60 seconds has passed, the reagent area 24 is then placed proximate to the graduated markings 26 and, specifically, between that pair of markings whose color or colors most closely matches the color or colors of the reagent area 24 of the test strip 22. If a match, or near match, is achieved, the glucose level registered in units of mg/dL is thereby determined. However, in the event the color developed at the reagent area 24 is darker than the color or colors portrayed by the graduated markings 26 for a level of 240 mg/dL (that is, the darkest color portrayed by any of the markings within the first set 26), the user is required to wait an additional 60 seconds after which the reaction color of the reagent area 24 is compared or matched with the second series of graduated markings 28. It will be appreciated that intermediate values of glucose concentrations can be estimated when the colors of the reagent area 24 are intermediate those on the vial 20.
The test just described is accurate and highly desirable. However, it has previously been mentioned, that it sometimes occurs that a diabetic person who would be the user of such a test would be sufficiently unsteady of hand that an accurate match could not be achieved within the restricted time period available.
The invention has been conceived and developed in order to assure an accurate result even when the user is unsteady of hand. Turn now to FIGS. 2 through 5 which illustrate the use of a registration device 32, which embodies the invention, in combination with the vial 20 which is of known shape, size, and construction.
As illustrated, the registration device 32 is slidably received on the outer peripheral surface 30 of the vial 20. It includes a central member 34 having a support region 36 (see especially FIG. 6) for slidably receiving the activated test strip 22, that is a test strip on which the blood sample (a drop) has been applied to the reagent area 24. The central member 34 also defines a window 38 extending therethrough for outlining or placing in registration, simultaneously, at least one set of the graduated markings 26, 28 on the peripheral surface 30 and on the reagent area 24 of the activated test strip 22 (see especially FIGS. 2 and 3).
The central member 34 includes first and second opposed side members 40 and 42, respectively, and the registration device 32 includes a pair of legs 44, 46 which extend away from the first and second side members 40, 42, respectively. Elongated protuberances formed on the inside of the side member 40, 42 serve as gripping members 48 at locations distant from the side members 40, 42 and serve to slidably engage the outer peripheral surface 30 of the vial 20. The central member 34 also includes an arcuate undersurface 50 which generally encompasses the window 38 and conforms to the outer peripheral surface 30 for slidable engagement therewith. Thus, it will be appreciated that the registration device 32 is slidably movable on the gripping members 48 and on the arcuate undersurface 50 both longitudinally along the length of the vial and circumferentially thereof. Of course, as the registration device 32 is moved, the window 38 is likewise moved.
Viewing especially FIGS. 6-8, the side member 40 defines an entry aperture 52 for slidably receiving a test strip 22 therethrough. The entry aperture 52 and the support region 36 coact to guide the test strip into registration within the window 38.
The side member 42 is formed with a slot 56 adjacent the window 38 which extends to a terminal surface 57 for engageably receiving an extreme end 58 of the test strip 22. As seen particularly in FIGS. 1 and 6, the reagent area 24 is spaced from the extreme end 58 by a region 60 which assures that the reagent area 24 is properly aligned with the markings 26 or 28 when those markings are within the opening defined by the window 38. With region 60 positioned proximate to the slot 56 and the extreme end 58 engaged with the terminal surface 57, the test strip 22 assumes an orientation which is substantially tangential relative to the outer peripheral surface 30 of the vial 20.
An added feature of the invention resides in the provision of a subcomponent 62 (FIGS. 11-14) which is removably mounted on a main component which includes the central member 34 and outwardly extending legs 44, 46. The subcomponent 62 defines an opening 64 for slidably receiving the test strip 22 and includes a nose member 66 which extends beyond the opening 64 and overlies the support region 36 when the subcomponent 62 is mounted on the side member 40. The subcomponent 62 includes opposed side walls 68, each of which has an elongated key 70 engageable with mating slots 72 formed in the side member 40. This construction enables the subcomponent to be moved between a fully disengaged position and an engaged position abutting the side member 40. Furthermore, the subcomponent 62 is preferably formed of at least moderately resilient material and includes an elongated slot 74 which cooperatively receives for engagement therein a mutually sized and shaped detent member 76 formed in the side member 40. The detent member 76 and slot 74 are mutually engaged when the subcomponent 62 reaches its operational position on the side member 40, that is, the position it assumes when it is ready to admit a test strip 22 within the opening 64 for advancement to the window 38.
When the opening 64, the entry aperture 52, and the support region 36 become undesirably filled or clogged with dried blood or other undesired residue, the subcomponent 62 can be pushed upwardly (see especially FIGS. 2, 4, and 5) so that the slot 74 is released from the detent member 76, allowing the subcomponent to move in the direction afforded by the keys 70 and mating slots 72 until the subcomponent 62 is completely free of the remainder of the structure. When this occurs, the subcomponent 62 can be cleaned as well as the remainder of the registration device 32. Thereupon, the subcomponent 62 can be reattached.
While a preferred embodiment of the invention has been disclosed in detail, it should be understood by those skilled in the art that other various modifications may be made to the illustrated embodiment without departing from the scope of the invention as described in the specification and defined in the appended claims.